Patents

US 9757350 B2: Small molecule inhibitors of replication protein A that also act synergistically with cisplatin

Granted
2017-09-12
Filed
2015-01-16 application 14598380
Type
Utility · 9 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Replication protein A (RPA) is a single-strand DNA-binding protein with essential roles in DNA replication, recombination and repair. Small molecule inhibitors (SMIs) with the ability to disrupt RPA binding activity to ssDNA have been identified and assessed using both lung and ovarian cancer cell lines. Lung cancer cell lines demonstrated increased apoptotic cell death following treatment with the SMI MCI13E, with IC50 values of ˜5 μM. The A2780 ovarian cancer cell line and the p53-null lung cancer cell line HI 299 were particularly sensitive to MCI13E treatment with IC50 values below 3 μM. Sequential treatment with MCI13E and cisplatin resulted in synergism, suggesting that decreasing RPA's DNA binding activity via a SMI may disrupt RPA's role in cell cycle regulation. Thus, RPA SMIs hold the potential to be used as single agent chemotherapeutics or in combination with current chemotherapeutic regimens to increase their efficacy.

Source: PVGPATDIS, file of 2026-04-10 (ipg170912.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Indiana University Research and Technology Corporation 488 patentsUS company or organizationIndianapolis, ININDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORP Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePVGPATDIS, file of 2026-04-10
Indiana State University 3 patentsUS company or organizationTerre Haute, INIndiana State University College or university EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
John J. TurchiIndianapolis, IN10PVGPATDIS, file of 2026-04-10
Richard W. FitchTerre Haute, IN4PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/22PVGPATDIS, file of 2026-04-10
C07DHeterocyclic compoundsC07D307/93PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2016-05-31Assignment
Assignment of assignor's interest
FITCH, RICHARD W. signed 2016-05-31INDIANA STATE UNIVERSITY TERRE HAUTE, IN38752/517ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.